首页> 外文OA文献 >OPEN LABEL STUDY OF THE EFFICACY AND SAFETY OF FIMASARTAN 60 MG ALONE AS INITIAL TREATMENT AND ITS RANDOMIZED ESCALATION TO FIMASARTAN 120 MG OR FIMASARTAN 60 MG/HYDROCHLOROTHIAZIDE 12.5 MG IN MEXICAN PATIENTS WITH ESSENTIAL HYPERTENSION GRADE 1 OR 2

【2h】

OPEN LABEL STUDY OF THE EFFICACY AND SAFETY OF FIMASARTAN 60 MG ALONE AS INITIAL TREATMENT AND ITS RANDOMIZED ESCALATION TO FIMASARTAN 120 MG OR FIMASARTAN 60 MG/HYDROCHLOROTHIAZIDE 12.5 MG IN MEXICAN PATIENTS WITH ESSENTIAL HYPERTENSION GRADE 1 OR 2

机译：开放性研究FIMASARTAN 60 MG作为初始治疗的有效性和安全性，并将其随机分配至FIMASARTAN 120 MG或FIMASARTAN 60 MG /氢氟氯噻嗪12.5 MG对具有基本高血压等级1或2的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Conde-Carmona Ignacio; Cardona Ernesto;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy [J] . Kim Kwang-il, Shin Mi-Seung, Ihm Sang-Hyun, Clinical therapeutics . 2016,第10期

机译：一项随机，双盲，多中心，III期研究，以评估Fimasartan /氨氯地平联合疗法与Fimasartan单一疗法相比对Fimasartan单一疗法无反应的原发性高血压患者的疗效和安全性
2. A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 x 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension [J] . Lee Hae-Young, Kim Yong-Jin, Ahn Taehoon, Clinical therapeutics . 2015,第11期

机译：一项随机，多中心，双盲，安慰剂对照，3 x 3因子设计II期研究，以评估菲马沙坦/氨氯地平联合治疗原发性高血压患者的疗效和安全性
3. Efficacy and safety of 30-Mg fimasartan for the treatment of patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, phase III clinical study [J] . YounJ.-C., IhmS.-H., BaeJ.-H., Clinical therapeutics . 2014,第10期

机译：30 mg氟马沙坦治疗轻度至中度高血压的疗效和安全性：一项为期8周的多中心，随机，双盲，III期临床研究
4. The efficacy and long-term safety of a triple combination of 80 mg telmisartan 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized double-blind study with open-label extension [O] . Jitsuo Higaki, Issei Komuro, Kosuke Shiki, -1

机译：80 mg替米沙坦5 mg氨氯地平和12.5 mg氢氯噻嗪三联组合在日本原发性高血压患者中的疗效和长期安全性：一项随机双盲研究采用开放标签扩展
5. A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy [O] . Kwang-il Kim, Mi-Seung Shin, Sang-Hyun Ihm, 2016

机译：随机，双盲，多中心，第三阶段研究，以评估Fimasartan / amlodipine联合治疗与Fimasartan单药治疗对Fimasartan单一疗法无响应的患者的疗效和安全性

OPEN LABEL STUDY OF THE EFFICACY AND SAFETY OF FIMASARTAN 60 MG ALONE AS INITIAL TREATMENT AND ITS RANDOMIZED ESCALATION TO FIMASARTAN 120 MG OR FIMASARTAN 60 MG/HYDROCHLOROTHIAZIDE 12.5 MG IN MEXICAN PATIENTS WITH ESSENTIAL HYPERTENSION GRADE 1 OR 2

著录项

相似文献

相关主题

期刊订阅